Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
System and method for updating firmware
Managing job execution
Portable electronic device housing including hinge
LED light
Topical antibiotic composition for the prevention of Lyme disease
Digital fine delay processing
Image display device and display unit for image display device
  Randomly Featured Patents
Method for the autostereoscopic presentation of image information with adaptation to suit changes in the head position of the observer
Fischer-Tropsch catalyst enhancement
Remote exposure of workpieces using a plasma
Liquid crystal ester compound
Set of containers
Optical mirror element
Remote control model car
Phase-control power controller with digital RMS load voltage regulation
Cutting head
Lateral deviation flat display screen